Latest Updates & News

New Hope for Alzheimer’s: Tackling Protein Clumps and Aging with Mitochondria Boosters

New Hope for Alzheimer’s: Tackling Protein Clumps and Aging with Mitochondria Boosters

What did the research discover? This study explored how amyloid beta (Aβ), a protein linked to Alzheimer’s disease (AD), accelerates the process of protein insolubility that naturally occurs with aging. Protein insolubility happens when proteins clump together and lose their normal function, a hallmark of neurodegenerative diseases like Alzheimer’s, Parkinson’s, and...

FDA New Update: New Treatments, Safety Alerts, and Medical Advancements

FDA New Update: New Treatments, Safety Alerts, and Medical Advancements

For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation...

Zonisamide for Epilepsy: Effectiveness, Safety, and Real-World Use

Zonisamide for Epilepsy: Effectiveness, Safety, and Real-World Use

What Did the Research Discover? Zonisamide is an anti-seizure medication that has been used since 1989 to treat epilepsy. It is approved for different types of seizures in various countries, including the U.S., Europe, Japan, and Korea. It can be taken alone or alongside other seizure medications. Studies show that zonisamide works through multiple mechanisms,...